Pfizer Names Oncology Head Boshoff

Pfizer names insider Chris Boshoff as R&D chief
Pfizer said on Wednesday it has named company veteran Chris Boshoff, who led the drugmaker's cancer research and marketing for more than a year, as its chief of research and development. The appointment comes at a time when Pfizer is facing pressure from activist investor Starboard,
Pfizer Names Chris Boshoff as New Chief Scientific Officer, R&D Chief
Chris Boshoff will take on the role of chief scientific officer starting Jan 1 & oversee all functions of research & development across all therapeutic area
Pfizer Names Oncology Head Boshoff as Chief Science Officer
Pfizer Inc. named oncology research head Chris Boshoff as the drug company’s chief scientific officer, replacing Mikael Dolsten, whose planned departure was announced earlier this year.
Pfizer names oncology head Chris Boshoff as R&D chief
Pfizer said on Wednesday it has named company veteran and oncology head Chris Boshoff as its chief of research and development. The appointment comes at a time when Pfizer is facing criticism from activist investor Starboard for overspending on big acquisitions and failing to produce profitable new drugs from those deals or its internal research and development.
Pfizer Names New R&D Chief
Company veteran Chris Boshoff, who has led Pfizer’s cancer research and marketing for more than a year, will become chief scientific officer starting Jan. 1.
Pfizer names oncology chief Chris Boshoff as new chief scientific officer
Pfizer Inc. named oncology chief Chris Boshoff as its new chief scientific officer on Wednesday, replacing Mikael Dolsten starting Jan. 1. The drug company had been searching for a new chief scientific officer since July with Dolsten leaving after 15 years at the company,
Pfizer Announces New Chief Scientific Officer and President, Research & Development
Pfizer Inc. (NYSE: PFE) today announced that after a comprehensive internal and external selection process, the company is appointing Chris Boshoff, M.D., PhD, as Chief Scientific Officer and President,
Doubling down on its strategy, Pfizer names its head of oncology as new research chief
Pfizer, despite pressure from investors to look outside, elevates its cancer chief Chris Boshoff to lead overall R&D.
ENDPOINTS NEWS4d
Pfiz­er taps on­col­o­gy head Boshoff as Dol­sten's chief sci­en­tif­ic of­fi­cer suc­ces­sor
Chris Boshoff will become Pfizer's chief scientific officer and R&D president on January 1, replacing Mikael Dolsten. Roger ...
devdiscourse3d
Global Health Updates: Innovations and Challenges in Fighting Diseases
Recent developments in health news highlight the CDC's anticipation of increased COVID-19 and RSV cases during the holidays, ...
Pfizer Taps Cancer Chief to Lead Research, Find Hit Drugs
Pfizer Inc. named oncology research head Chris Boshoff as the drug company’s chief scientific officer while it works to fend ...
Leerink views Chris Boshoff as ‘strong choice’ for Pfizer’s CSO
Leerink notes Pfizer (PFE) announced that Chris Boshoff will become the new Chief Scientific Officer, succeeding Mikael Dolsten. The firm views ...
Pfizer promotes oncology chief to lead R&D as activist Starboard circles
Pfizer has promoted its oncology chief to lead all of its research and development operations, in a move that will be closely watched by the activist investor piling pressure on the struggling ...